Zentalis Pharmaceuticals, Inc.
NASDAQ:ZNTLBiotechnology
Healthcare
$1.36 +0.83%
+$0.03 today
- Market cap
- $133.64M
- Beta
- 1.98
- P/E (TTM)
- -2.1
- EPS (TTM)
- -$1.77
52W Low $1.13High $6.95
Volume 1.45M
Average 2.00M
Price history
Zentalis Pharmaceuticals, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+2.26%
Period high
$6.61
Period low
$1.30
Latest
$1.36
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 9, 2026 | Nov 9, 2026 | |
| 8-K | Nov 9, 2026 | Nov 9, 2026 | |
| SC 13G/A | Oct 27, 2026 | Oct 27, 2026 | |
| 4 | Oct 1, 2026 | Oct 1, 2026 | |
| 4 | Aug 19, 2026 | Aug 19, 2026 | |
| SC 13G/A | Aug 19, 2026 | Aug 19, 2026 | |
| 424B5 | Aug 14, 2026 | Aug 14, 2026 | |
| 8-K | Aug 14, 2026 | Aug 14, 2026 | |
| 424B5 | Aug 13, 2026 | Aug 13, 2026 | |
| SC 13G/A | Aug 13, 2026 | Aug 13, 2026 | |
| 10-Q | Aug 6, 2026 | Aug 6, 2026 | |
| 8-K | Aug 6, 2026 | Aug 6, 2026 | |
| SC 13G | Jul 30, 2026 | Jul 30, 2026 | |
| 4 | Jun 18, 2026 | Jun 18, 2026 | |
| 4 | Jun 18, 2026 | Jun 18, 2026 |
Competitors
Who does Zentalis Pharmaceuticals, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about ZNTL's filings, answered from its disclosures.
What is the latest ZNTL filing?
The latest filing shown is 8-K dated Nov 9, 2026.
How many recent filings does ZNTL have?
Intrinsic Alpha currently shows 20 recent filings for ZNTL.
Continue the stock analysis
Jump to another research area for this company.